Cormorant Global Healthcare Master Fund, LP, Director Other at Prometheus Biosciences, Inc. (RXDX), bought 2,223,022 shares at $19.00 ($7.1M) on 2021-03-16, disclosed to the SEC on 2021-03-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,848,022 | $0 | 0.0% |
| 2 | $19.00 | 375,000 | $7.1M | 100.0% |
| Total | $3.21 avg | 2,223,022 | $7.1M | 100% |
| Filing → |
| DRUG | BUY | 2024-10-17 | $6.4M | — | Filing → |
| CRBP | BUY | 2024-09-24 | $14.0M | — | Filing → |
| EYPT | BUY | 2024-04-22 | $21.0M | — | Filing → |